Betamethasone Dipropionate Ointment
Product Images NDC 45802-505

2 FDA label images from Padagis Israel Pharmaceuticals Ltd · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Betamethasone Dipropionate (NDC 45802-505). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 01)

Structure (Image 01)
Chemical structure of betamethasone dipropionate, showing its molecular formula C28H37FO7 and molecular weight 504.60.*
FDA Label Image

Betamethasone Dipropionate Ointment Usp, 0.05% Carton (65m14rcc2)

Betamethasone Dipropionate Ointment Usp, 0.05% Carton (65m14rcc2)
Betamethasone Dipropionate Ointment USP 0.05% topical ointment carton for dermatologic use only, not for ophthalmic use. Each 15 g package contains ointment with potency expressed as betamethasone. Label features the Padagis logo and states the product is manufactured by Padagis in Israel. Includes dosage instructions, tamper-resistant seal warning, and storage information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.